Riskpilot← Back to searchSign inGet full accessINDERØY DYREKLINIKK AS
ASActiveOrg 979759223Vennalivegen 2, 7670 InderøyVeterinary activities · NACE 7500Est. 19988 employeeswww.dyrlegene.com
Revenue 2024
NOK 18,1M
+15% vs 2023
EBITDA margin
45.1%
+11% vs 2023
Equity ratio
4.7%
Financial strength
Net profit 2024
NOK 6,6M
-25% vs 2023
| Revenue | NOK 18,1M | +15% |
| EBITDA | NOK 8,1M | +11% |
| Net profit | NOK 6,6M | -25% |
| Total assets | NOK 11,3M | -7% |
| Equity | NOK 527K | +20% |
| Employees | 8 | — |
Legal name
INDERØY DYREKLINIKK AS
Org number
979759223
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
24. mars 1998
Share capital
NOK 100 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drive veterinærklinikk, samt annen virksomhet som naturlig står i forbindelse med dette.
Address
Vennalivegen 2, 7670 Inderøy
Website
www.dyrlegene.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 817 | 14 201 | 14 397 | 15 745 | 18 063 |
| Staff expenses | −3 644 | −3 828 | −4 109 | −4 180 | −5 092 |
| EBITDA | 5 338 | 6 007 | 6 612 | 7 314 | 8 141 |
| Depreciation & amort. | −189 | −183 | −183 | −110 | −110 |
| EBIT | 5 149 | 5 824 | 6 428 | 7 204 | 8 031 |
| Net financials | 78 | 19 | 29 | 3 190 | 416 |
| Profit before tax | 5 228 | 5 844 | 6 458 | 10 394 | 8 446 |
| Tax | 1 150 | 1 286 | 1 421 | 1 629 | 1 859 |
| Net profit | 4 077 | 4 558 | 5 037 | 8 765 | 6 587 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 673 | 7 483 | 8 128 | 12 222 | 11 305 |
| Equity | 1 030 | 138 | 175 | 440 | 527 |
| Long-term debt | 81 | 60 | 39 | 12 | 0 |
| Short-term debt | 8 563 | 7 285 | 7 915 | 11 770 | 10 778 |
| Total debt | 8 643 | 7 346 | 7 953 | 11 782 | 10 778 |
EBITDA margin
45.1%
This company
15.8%
Market median
+185% vs market
20202024
Equity ratio
4.7%
This company
38.2%
Market median
-88% vs market
20202024
Return on equity
1249.7%
This company
18.4%
Market median
+6692% vs market
20202024
Net profit margin
36.5%
This company
8.1%
Market median
+351% vs market
20202024
Asset turnover
1.60×
This company
1.12×
Market median
+43% vs market
20202024
Debt / equity
20.45×
This company
0.62×
Market median
-3198% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EH Deputy Member | Deputy Member | 2005 |
SB Chief Executive Officer | Chief Executive Officer | 1998 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2005 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INDERØY DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elisabeth Hammer | Deputy Member | 0 companies |
| Ståle Brattgjerd | Chief Executive Officer | 0 companies |
| Tore Sandvik | Chairman | 0 companies |